StocksFundsScreenerSectorsWatchlists
ISRG

ISRG - Intuitive Surgical Inc Stock Price, Fair Value and News

366.26USD-6.37 (-1.71%)Market Closed

Market Summary

ISRG
USD366.26-6.37
Market Closed
-1.71%

ISRG Alerts

  • 2 major insider sales recently.

ISRG Stock Price

View Fullscreen

ISRG RSI Chart

ISRG Valuation

Market Cap

129.9B

Price/Earnings (Trailing)

65.36

Price/Sales (Trailing)

17.75

EV/EBITDA

54.28

Price/Free Cashflow

76.07

ISRG Price/Sales (Trailing)

ISRG Profitability

Operating Margin

85.95%

EBT Margin

28.36%

Return on Equity

14.15%

Return on Assets

12.56%

Free Cashflow Yield

1.31%

ISRG Fundamentals

ISRG Revenue

Revenue (TTM)

7.3B

Rev. Growth (Yr)

11.46%

Rev. Growth (Qtr)

-1.96%

ISRG Earnings

Earnings (TTM)

2.0B

Earnings Growth (Yr)

53.36%

Earnings Growth (Qtr)

-10.11%

Breaking Down ISRG Revenue

Last 7 days

-4.8%

Last 30 days

-6.2%

Last 90 days

-2.3%

Trailing 12 Months

23.2%

How does ISRG drawdown profile look like?

ISRG Financial Health

Current Ratio

5.55

ISRG Investor Care

Shares Dilution (1Y)

1.23%

Diluted EPS (TTM)

5.54

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20247.3B000
20236.4B6.7B6.9B7.1B
20225.9B6.0B6.1B6.2B
20214.6B5.2B5.5B5.7B
20204.6B4.4B4.3B4.4B
20193.9B4.0B4.2B4.5B
20183.3B3.5B3.6B3.7B
20172.8B2.9B3.0B3.1B
20162.4B2.5B2.6B2.7B
20152.2B2.3B2.3B2.4B
20142.1B2.1B2.1B2.1B
20132.3B2.3B2.3B2.3B
20121.9B2.0B2.1B2.2B
20111.5B1.5B1.6B1.8B
20101.2B1.3B1.3B1.4B
2009875.1M916.5M960.6M1.1B
20080692.2M783.5M874.9M
2007000600.8M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Intuitive Surgical Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 15, 2024
widman fredrik
sold
-1,758,620
397
-4,429
vp corporate controller
Mar 15, 2024
widman fredrik
acquired
36,247
59.2278
612
vp corporate controller
Mar 11, 2024
brosius mark
sold
-76,471
390
-196
svp & chief mfg and supply cha
Mar 11, 2024
desantis robert
sold
-128,363
390
-329
evp & chief strategy & corp op
Mar 11, 2024
desantis robert
acquired
79,955
243
329
evp & chief strategy & corp op
Mar 08, 2024
desantis robert
acquired
4,383,440
297
14,728
evp & chief strategy & corp op
Mar 08, 2024
brosius mark
sold
-76,835
392
-196
svp & chief mfg and supply cha
Mar 08, 2024
desantis robert
sold
-7,992,510
393
-20,296
evp & chief strategy & corp op
Mar 07, 2024
brosius mark
sold
-77,086
393
-196
svp & chief mfg and supply cha
Mar 06, 2024
brosius mark
sold
-75,805
386
-196
svp & chief mfg and supply cha

1–10 of 50

Which funds bought or sold ISRG recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 18, 2024
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.
added
33.54
624,000
1,700,000
0.01%
Apr 18, 2024
WOLFF WIESE MAGANA LLC
added
0.37
69,005
437,403
0.38%
Apr 18, 2024
AlphaMark Advisors, LLC
reduced
-5.56
2,000
14,000
-%
Apr 18, 2024
SILVIA MCCOLL WEALTH MANAGEMENT, LLC
reduced
-2.02
32,089
282,410
0.24%
Apr 18, 2024
MCRAE CAPITAL MANAGEMENT INC
reduced
-2.46
211,024
1,582,390
0.35%
Apr 18, 2024
ARK Investment Management LLC
reduced
-11.5
662,407
14,760,300
0.10%
Apr 18, 2024
CULLINAN ASSOCIATES INC
added
300
2,014,400
2,554,180
0.14%
Apr 18, 2024
Diversified Trust Co
added
7.86
567,409
2,623,620
0.08%
Apr 18, 2024
FARMERS & MERCHANTS TRUST Co OF LONG BEACH
added
0.79
57,610
357,185
0.09%
Apr 18, 2024
Claro Advisors LLC
added
25.04
105,884
326,855
0.06%

1–10 of 48

Are Funds Buying or Selling ISRG?

Are funds buying ISRG calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ISRG
No. of Funds

Unveiling Intuitive Surgical Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
price t rowe associates inc /md/
4.8%
16,990,447
SC 13G/A
Feb 13, 2024
vanguard group inc
8.63%
30,375,212
SC 13G/A
Jan 25, 2024
blackrock inc.
8.4%
29,575,972
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
5.9%
20,823,995
SC 13G/A
Feb 09, 2023
vanguard group inc
8.33%
29,425,186
SC 13G/A
Feb 03, 2023
blackrock inc.
8.0%
28,447,145
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
6.9%
24,756,021
SC 13G/A
Feb 07, 2022
blackrock inc.
7.4%
26,538,660
SC 13G/A
Feb 16, 2021
price t rowe associates inc /md/
8.1%
9,599,898
SC 13G/A
Feb 10, 2021
vanguard group inc
7.76%
9,127,891
SC 13G/A

Recent SEC filings of Intuitive Surgical Inc

View All Filings
Date Filed Form Type Document
Apr 19, 2024
10-Q
Quarterly Report
Apr 18, 2024
8-K
Current Report
Mar 18, 2024
4
Insider Trading
Mar 15, 2024
144
Notice of Insider Sale Intent
Mar 14, 2024
8-K
Current Report
Mar 11, 2024
144
Notice of Insider Sale Intent
Mar 11, 2024
144
Notice of Insider Sale Intent
Mar 11, 2024
4
Insider Trading
Mar 11, 2024
4
Insider Trading
Mar 08, 2024
144
Notice of Insider Sale Intent

Peers (Alternatives to Intuitive Surgical Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
186.2B
40.1B
-3.77% -2.76%
32.53
4.64
-8.12% -17.45%
67.7B
19.5B
-1.53% -10.57%
53.87
3.47
4.02% -22.04%
22.5B
3.9B
-9.16% -15.16%
50.45
5.81
3.42% 23.09%
20.0B
14.8B
-5.62% -8.72%
7.55
1.35
2.12% 209.17%
MID-CAP
9.2B
3.5B
-0.49% 17.01%
32.32
2.64
4.97% 18.89%
9.1B
12.3B
-5.22% -14.61%
21.9
0.74
-2.44% -22.68%
8.2B
2.7B
-16.90% -39.13%
-12.81
3.06
-4.68% 82.43%
6.3B
4.0B
-8.41% -25.34%
-47.02
1.6
1.10% 85.84%
3.4B
366.4M
-2.66% 12.41%
-562.39
9.32
33.86% 89.83%
2.3B
6.6B
-4.93% -3.92%
12.04
0.35
2.78% -0.87%
SMALL-CAP
1.2B
3.2B
-14.38% -20.49%
-1.83
0.39
7.73% -1066.14%
383.3M
166.7M
0.86% -5.21%
-4.64
2.3
6.67% -456.34%
250.3M
324.0M
11.81% -29.38%
-1.3
0.77
-3.19% -337.41%
45.7M
52.3M
-28.65% -55.25%
-2.44
0.87
17.61% 19.28%
3.8M
3.7M
-10.98% 147.46%
-0.31
1.02
5.77% 8.23%

Intuitive Surgical Inc News

Latest updates
Yahoo Finance12 hours ago
Yahoo Finance30 hours ago
Yahoo Finance17 Apr 202412:32 pm
Zacks Investment Research16 Apr 202406:30 pm

Intuitive Surgical Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-2.0%1,8911,9281,7441,7561,6961,6551,5571,5221,4881,5511,4031,4641,2921,3291,0788521,1001,2781,1281,099974
Gross Profit-2.5%1,2451,2771,1671,1721,1131,1111,0521,0231,0101,0619711,024903896724503738896786759670
Operating Expenses-6.2%776827701709725738653626602610529513486480454422455498420400417
  S&GA Expenses-13.3%492567452464481494436418391427363350326330299279308342284279273
  R&D Expenses9.4%285260249244245244217207211183166162160150155143147157136121144
EBITDA Margin2.5%0.32*0.31*0.31*0.30*0.29*0.30*0.32*0.33*0.36*0.38*0.39*0.39*0.35*0.32*-------
Income Taxes90.6%-8.90-94.8010273.0061.0058.0078.0093.0033.0072.0074.003.0014.0073.0038.0037.00-8.1069.000.0075.00-24.30
Earnings Before Taxes4.4%539516522499422395403407402454461526449437355107308432399392280
EBT Margin3.1%0.28*0.27*0.27*0.26*0.25*0.26*0.27*0.29*0.31*0.33*0.34*0.34*0.30*0.28*-------
Net Income-10.1%54560641642135532532430836638138151742636531468.00314358397318307
Net Income Margin7.6%0.27*0.25*0.22*0.21*0.20*0.21*0.23*0.24*0.28*0.30*0.31*0.31*0.26*0.24*-------
Free Cashflow16.3%265228548666371438383447223568501543478628-------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets2.5%15,82815,44214,71313,90313,05312,97413,26113,70513,67813,55512,93512,29711,54011,16910,61810,1049,8919,7339,1318,5328,235
  Current Assets-3.2%7,6337,8888,9038,0326,8776,2536,2936,2935,8035,8455,7286,0176,0666,6266,3005,8994,6924,6634,3174,0724,025
    Cash Equivalents4.3%2,8672,7503,6023,4352,1431,5811,5541,5511,1181,3061,3621,6311,4181,6391,3862,0521,2391,183985805891
  Inventory6.4%1,2991,2211,1481,005947893837724653587585570577602663646620596580513468
  Net PPE7.4%3,8003,5383,0772,8312,5802,3742,2442,1091,9681,8761,7381,6511,5931,5771,5101,4501,3691,2731,1371,032935
  Goodwill-0.1%348349348349349349348349343344344344345337336337335307305245248
Liabilities-12.8%1,7822,0442,0891,9441,7591,8611,6871,6231,5221,6041,4751,4181,3501,4101,3311,3371,3611,4491,3541,2521,195
  Current Liabilities-17.1%1,3751,6591,6761,5381,3071,4221,2331,1751,1121,1501,0271,0059059658959259461,030931808740
Shareholder's Equity5.6%14,04613,30812,53911,96011,29411,04211,57412,08212,15711,95211,46010,88010,1909,7599,2878,7668,5318,2857,7777,2807,040
  Retained Earnings6.9%5,0684,7434,2093,8083,3973,5004,0184,6834,8584,7614,3904,0233,5153,2612,9372,6332,5712,4952,1431,8191,696
  Additional Paid-In Capital3.8%8,9038,5768,3868,1517,9287,7047,6857,4847,3557,1647,0156,8046,6276,4456,3046,0855,9275,7575,6015,4305,329
Accumulated Depreciation-100.0%-1,562---1,238---969---758---563---
Shares Outstanding0.7%355352352351350350357358358356357356354--------
Minority Interest-6.6%84.0090.0085.0081.0077.0071.0059.0059.0055.0050.0049.0042.0037.0028.0029.0026.0024.0021.0016.0014.0016.00
Float----119,600---71,400---108,700---66,400---59,900-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations16.3%265228548666371438383447223568501543478628275230353553396316333
  Share Based Compensation1.9%15315015614714012813812712111812010810310310696.0091.0089.0089.0082.0076.00
Cashflow From Investing87.7%-128-1,044-446558573575545466-214-641-838-384-597-334-1,025537-117-406-216-222-308
Cashflow From Financing-48.3%-46.70-31.5062.0063.00-381-963-926-482-19919.0068.0058.00-102-39.8085.0048.00-17851.001.00-178-41.80
  Buy Backs-100.0%-66.00--3501,0011,000500107----34.00--100-70.00200-

ISRG Income Statement

2023-12-31
Consolidated Statements Of Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue:   
Total revenue$ 7,124.1$ 6,222.2$ 5,710.1
Cost of revenue:   
Total cost of revenue2,394.62,026.21,751.6
Gross profit4,729.54,196.03,958.5
Operating expenses:   
Selling, general and administrative1,963.91,739.91,466.5
Research and development998.8879.0671.0
Total operating expenses2,962.72,618.92,137.5
Income from operations1,766.81,577.11,821.0
Interest and other income, net192.129.769.3
Income before taxes1,958.91,606.81,890.3
Income tax expense141.6262.4162.2
Net income1,817.31,344.41,728.1
Less: net income attributable to noncontrolling interest in joint venture19.322.123.5
Net income attributable to Intuitive Surgical, Inc.$ 1,798.0$ 1,322.3$ 1,704.6
Net income per share attributable to Intuitive Surgical, Inc.:   
Basic (usd per share)$ 5.12$ 3.72$ 4.79
Diluted (usd per share)$ 5.03$ 3.65$ 4.66
Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:   
Basic (shares)351.2355.7356.1
Diluted (shares)357.4362.0365.8
Joint venture   
Operating expenses:   
Less: net income attributable to noncontrolling interest in joint venture$ 19.3$ 22.1$ 23.5
Product   
Revenue:   
Total revenue5,956.35,198.04,793.9
Cost of revenue:   
Total cost of revenue2,041.81,700.31,464.1
Service   
Revenue:   
Total revenue1,167.81,024.2916.2
Cost of revenue:   
Total cost of revenue$ 352.8$ 325.9$ 287.5

ISRG Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 2,750.1$ 1,581.2
Short-term investments2,473.12,536.7
Accounts receivable, net of allowances of $27.1 and $22.4 as of December 31, 2023, and 2022, respectively1,130.2942.1
Inventory1,220.6893.2
Prepaids and other current assets314.0299.8
Total current assets7,888.06,253.0
Property, plant, and equipment, net3,537.62,374.2
Long-term investments2,120.02,623.6
Deferred tax assets910.5664.6
Intangible and other assets, net636.7710.1
Goodwill348.7348.5
Total assets15,441.512,974.0
Current liabilities:  
Accounts payable188.7147.0
Accrued compensation and employee benefits436.4401.6
Deferred revenue446.1397.3
Other accrued liabilities587.5476.2
Total current liabilities1,658.71,422.1
Other long-term liabilities385.5439.3
Total liabilities2,044.21,861.4
Commitments and contingencies (Note 8)
Stockholders’ equity:  
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of December 31, 2023, and 20220.00.0
Common stock, 600.0 shares authorized, $0.001 par value, 352.3 shares and 350.0 shares issued and outstanding as of December 31, 2023, and 2022, respectively0.40.4
Additional paid-in capital8,576.47,703.9
Retained earnings4,743.03,500.1
Accumulated other comprehensive loss(12.2)(162.5)
Total Intuitive Surgical, Inc. stockholders’ equity13,307.611,041.9
Noncontrolling interest in joint venture89.770.7
Total stockholders’ equity13,397.311,112.6
Total liabilities and stockholders’ equity$ 15,441.5$ 12,974.0
ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
 CEO
 WEBSITEintuitive.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES12120

Intuitive Surgical Inc Frequently Asked Questions


What is the ticker symbol for Intuitive Surgical Inc? What does ISRG stand for in stocks?

ISRG is the stock ticker symbol of Intuitive Surgical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Intuitive Surgical Inc (ISRG)?

As of Fri Apr 19 2024, market cap of Intuitive Surgical Inc is 129.04 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ISRG stock?

You can check ISRG's fair value in chart for subscribers.

What is the fair value of ISRG stock?

You can check ISRG's fair value in chart for subscribers. The fair value of Intuitive Surgical Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Intuitive Surgical Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ISRG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Intuitive Surgical Inc a good stock to buy?

The fair value guage provides a quick view whether ISRG is over valued or under valued. Whether Intuitive Surgical Inc is cheap or expensive depends on the assumptions which impact Intuitive Surgical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ISRG.

What is Intuitive Surgical Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 19 2024, ISRG's PE ratio (Price to Earnings) is 71.77 and Price to Sales (PS) ratio is 18.11. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ISRG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Intuitive Surgical Inc's stock?

In the past 10 years, Intuitive Surgical Inc has provided 0.228 (multiply by 100 for percentage) rate of return.